Inverse H&S in pharma index could revive a positive bias for short-term

Pharma shares like Aurobindo Pharma, Zydus Lifesciences, Sun Pharmaceutical Industries Ltd, Glenmark Pharmaceuticals may rise up to 14 per cent.

Avdhut Bagkar Mumbai
Illustration: Binay Sinha

Pharma index is poised for a short term upside

Listen to This Article

Shares of pharmaceutical companies to remain in spotlight following the index broke out of the “Inverse Head and Shoulder” pattern. While the broad trend bares weakness, the current formation may provide some respite. 
Aurobindo Pharma, for instant, has conquered the key indicator, the 200-day moving average after August 2021. Zydus Lifesciences shares have gradually raising upward, with no impact of the overall stock market trend. Divi's Laboratories and Glenmark Pharmaceuticals are both firmly holding their fort over the 200-DMA. 
Shares of NATCO Pharma soared over 2 per cent, while Glenmark Pharmaceuticals and Divi's Laboratories gained 1.74 per cent and 1.20 per cent, respectively, in comparison to the benchmark indices, which slipped close to 0.25 per cent. 

Also Read

Nifty Pharma index surpasses 200-DMA; Cipla, Granules can soar up to 15%

Pharma shares may turnaound soon; Cipla, Sun Pharma, Granules can gain 20%

Can Bira 91 deal trigger gains for alcohol stocks? Here's what charts say

Nifty Pharma dips to 7-mth low; bears may gain control if breaks 52-wk low

LIC, Indiabulls Housing Finance struggle on charts; HDFC eyes Rs 2,700-mark

Deadline for nomination for demat, trading accounts extended till Sept 30

Bandhan Bank crashes to 3-year low on asset quality concerns

PNC Infra rallies 8% on bagging Rs 819 crore highway project

Kalyan Jewellers tanks 11% on large block deal; over 39 mn shares exchanged

Inflation, rate hikes play market party poopers in FY23; smallcaps hit hard

Zydus Lifesci.

  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 5Y
  • MAX

First Published: Mar 28 2023 | 11:44 AM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on are available only to BS Premium subscribers. Already a BS Premium subscriber?LOGIN NOW

Register to